Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Keratinocyte Growth Factor in Bone Marrow Transplants for GVHD Prevention
NCT00056875Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Sep 2002
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human keratinocyte growth factor in graft-versus-host disease (GVHD), sponsored by University of Michigan. Started Sep 2002; status: completed.
02
Drugs
human keratinocyte growth factor
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00056875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056875.